Biopharma | April 14, 2026
Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The company says the platform offers improved manufacturability and functional advantages
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
Subscribe To Our Newsletter & Stay Updated
